154 related articles for article (PubMed ID: 26914491)
1. The Japanese Breast Cancer Society clinical practice guidelines for pathological diagnosis of breast cancer, 2015 edition.
Horii R; Honma N; Ogiya A; Kozuka Y; Yoshida K; Yoshida M; Horiguchi S; Ito Y; Mukai H
Breast Cancer; 2016 May; 23(3):391-9. PubMed ID: 26914491
[No Abstract] [Full Text] [Related]
2. The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer.
Horii R; Honma N; Ogiya A; Kozuka Y; Fukuda T; Yoshida M; Ohsumi S; Mukai H;
Breast Cancer; 2015 Jan; 22(1):59-65. PubMed ID: 25022266
[No Abstract] [Full Text] [Related]
3. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
[TBL] [Abstract][Full Text] [Related]
4. Pathological examination of breast cancer biomarkers: current status in Japan.
Masuda S
Breast Cancer; 2016 Jul; 23(4):546-51. PubMed ID: 25239167
[TBL] [Abstract][Full Text] [Related]
5. Sentinel node biopsy in breast cancer: time has come to systematically perform it before planned axillary clearance.
Hidar S; Bibi M; Khairi H
Breast; 2010 Feb; 19(1):65-6. PubMed ID: 19896849
[TBL] [Abstract][Full Text] [Related]
6. [A novel cell block technique for fine needle aspiration biopsy samples].
Chen GY; Yu XM; Liu J; You QH; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):558-9. PubMed ID: 22169648
[No Abstract] [Full Text] [Related]
7. Comparison of sonography with sonographically guided fine-needle aspiration biopsy and core-needle biopsy for initial axillary staging of breast cancer.
Ahn HS; Kim SM; Jang M; La Yun B; Kim SW; Kang E; Park SY; Moon WK; Choi HY
J Ultrasound Med; 2013 Dec; 32(12):2177-84. PubMed ID: 24277901
[TBL] [Abstract][Full Text] [Related]
8. Association of the involvement of axillary lymph nodes in HER-2/neu overexpression in patients with breast cancer.
Ziaeemehr A; Shahidsales S; Ghosi Z; Avan A; Aldavood AS; Anvari K; Makhdoomi Y; Asadi M
Breast J; 2019 May; 25(3):537-538. PubMed ID: 30973656
[No Abstract] [Full Text] [Related]
9. Comparison of the expression of prognostic biomarkers between primary tumor and axillary lymph node metastases in breast cancer.
Zhao S; Xu L; Liu W; Lv C; Zhang K; Gao H; Wang J; Ma R
Int J Clin Exp Pathol; 2015; 8(5):5744-8. PubMed ID: 26191291
[TBL] [Abstract][Full Text] [Related]
10. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
11. The current topics of surgical pathology of breast cancer in Japan.
Moriya T
Breast Cancer; 2016 Jul; 23(4):533. PubMed ID: 27193427
[No Abstract] [Full Text] [Related]
12. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-guided fine-needle aspiration detects nonpalpable axillary metastases in breast cancer patients who are candidates for the sentinel lymph node procedure.
Maia MA; Chojniak R; Lima EN; Marques EF; Maciel Mdo S
Breast J; 2011; 17(3):317-8. PubMed ID: 21492298
[No Abstract] [Full Text] [Related]
14. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
15. Relevance and methods of interventional breast sonography in preoperative axillary lymph node staging.
Gruber I; Hahn M; Fehm T; Hann von Weyhern C; Stäbler A; Winckelmann A; Wallwiener D; Kühn T
Ultraschall Med; 2012 Aug; 33(4):337-43. PubMed ID: 21618166
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer prognosis and isolated tumor cell findings in axillary lymph nodes after core needle biopsy and fine needle aspiration cytology: Biopsy method and breast cancer outcome.
Liikanen J; Leidenius M; Joensuu H; Vironen J; Heikkilä P; Meretoja T
Eur J Surg Oncol; 2016 Jan; 42(1):64-70. PubMed ID: 26427542
[TBL] [Abstract][Full Text] [Related]
17. Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node.
Tvedskov TF; Bartels A; Jensen MB; Paaschburg B; Kroman N; Balslev E; Brünner N
APMIS; 2011 Dec; 119(12):844-52. PubMed ID: 22085360
[TBL] [Abstract][Full Text] [Related]
18. Images in pathology. Dove in flight: who will save the dove?
Testi MA; Cabras A
Int J Surg Pathol; 2006 Apr; 14(2):144. PubMed ID: 16703177
[No Abstract] [Full Text] [Related]
19. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
[TBL] [Abstract][Full Text] [Related]
20. [Breast carcinoma: evaluation of hormone receptors and pS2, erb-B2, P-glycoprotein and Ki-67 markers].
Abadjian G; Antoun R
J Med Liban; 1996; 44(1):10-5. PubMed ID: 8965315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
